Recent Updates
Recently added Catalysts
IONS Positive Sentiment

Ionis to hold second quarter 2024 financial results webcast Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Thursday, August 1st at 11:30 a.m. Eastern Time to...

Key Takeaway: Ionis Pharmaceuticals, Inc. announced a live webcast scheduled for August 1, 2024, at 11:30 a.m. Eastern Time to discuss its second quarter financial results. The webcast will be accessible online, and a replay will be available for a limited time. Ionis continues to innovate in RNA-targeted medicines and gene editing.
Price reaction · baseline $47.33 (2024-07-18 close) · hit after-hours · 1 other IONS headline(s) in the window, move may be shared
day 0 close · peak
+1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Ionis is hosting a live webcast to discuss financial results.
  • The company has a strong pipeline in neurology and cardiology.
  • Ionis has a history of inventing medicines for serious diseases.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+24%
120-day peak, hindsight
Typical move
4.1%
average across 11 past catalysts
Lead asset
ISIS 113715
Phase 2 · Type 2 Diabetes Mellitus

Full Press Release Details

Webcast scheduled for Thursday, August 1 at 11:30 a.m. Eastern Time
CARLSBAD, Calif. , July 19, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS ) announced today that it will host a live webcast on Thursday, August 1 st at 11:30 a.m. Eastern Time to discuss its second quarter 2024 financial results.
The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events . A replay will be available for a limited time at the same address.
About Ionis Pharmaceuticals, Inc. For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn .

Frequently Asked Questions

When is the Ionis Q2 2024 webcast scheduled?

The Ionis Q2 2024 webcast is scheduled for August 1, 2024, at 11:30 a.m. Eastern Time.

How can I access the Ionis webcast?

The webcast can be accessed at Ionis's investor relations website.

Will there be a replay of the Ionis webcast?

Yes, a replay of the webcast will be available for a limited time.

What does Ionis focus on in its research?

Ionis focuses on RNA-targeted medicines and has a leading pipeline in neurology and cardiology.

Last updated: Jul 19, 2024